Enabling The Cure of 100 Rare Diseases in 10 Years
CENTOGENE is the unique and essential partner for patients, physicians, and biopharma, from diagnostics to discovery to clinical development to market access & expansion in rare, metabolic, and neurodegenerative diseases.
Individuals in the CENTOGENE Biodatabank
Active physicians in our network
Genes covered in testing portfolio
CentoCloud – Decentralized Diagnostics
CENTOGENE provides premium quality services to ensure our customers achieve their goals & objectives in delivering the highest quality diagnostics to their patients. But what does this exactly look like in action? Keep reading to learn how you can analyze, interpret, and report genomic variants with our decentralized diagnostic solution.
To create a map, we integrate omic data from patients with the same disease to form an atlas representing a comprehensive collection of unique and detailed clinical and biochemical information about each rare disease.
Understanding the details of disease pathways – faulty genes and how they affect associated proteins, and how that leads to specific symptoms – can provide our pharmaceutical partners with valuable clues on how best to research treatments, by developing a drug to target specific molecules along disease pathways for example.
The combination of omic technologies can identify drugs and drug targets with greater certainty, reducing the risk of failure and making drug development for rare diseases more financially attractive to pharma. Our goal: to enable the cure of 100 diseases in 10 years.